NL
LLY icon

NKCFO LLC’s Eli Lilly LLY Stock Holding History

NKCFO LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Sell
2,195
-5
-0.2% -$5.11K 0.8% 33
2026
Q1 		$2.02M Sell
2,200
-100
-4% -$101K 0.6% 41
2025
Q4 		$2.47M Buy
2,300
+300
+15% +$287K 0.71% 36
2025
Q3 		$1.53M Buy
+2,000
New +$1.49M 0.46% 42
2025
Q2 		– Sell
-115
Closed -$95K – 105
2025
Q1 		$95K Buy
+115
New +$95.7K 0.04% 74
2024
Q4 		– Sell
-1,800
Closed -$1.59M – 125
2024
Q3 		$1.59M Buy
1,800
+50
+3% +$45K 0.76% 27
2024
Q2 		$1.58M Buy
+1,750
New +$1.4M 0.86% 25

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NKCFO LLC's LLY Position: Q2 2026 in Review

NKCFO LLC reduced its Eli Lilly (LLY) stake by 0.23% in Q2 2026, selling an estimated $5.11K and leaving 2,195 shares worth $2.63M. The position accounts for 0.8% of the portfolio, ranked #33.

NKCFO LLC first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NKCFO LLC held 2,195 shares of Eli Lilly worth $2.63M as of Q2 2026.
  • NKCFO LLC sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.8% of NKCFO LLC's portfolio in Q2 2026, its #33 holding.
  • NKCFO LLC first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NKCFO LLC's 13F filing for Q2 2026, filed 13 Aug 2026.